The reno-cardiovascular connection in the patient with Diabetes mellitus: What's new?
Endocrinol Diabetes Nutr. 2017 May;64(5):237-240.
doi: 10.1016/j.endinu.2017.03.006.
Epub 2017 Apr 26.
[Article in
English,
Spanish]
Affiliations
- 1 Departamento de Nefrología, Hospital del Mar-Institut Hospital del Mar d'Investigacions Mèdiques, REDINREN, Barcelona, España.
- 2 Departamento de Nefrología, Hospital del Mar-Institut Hospital del Mar d'Investigacions Mèdiques, REDINREN, Barcelona, España. Electronic address: [email protected].
No abstract available
MeSH terms
-
Albuminuria / etiology
-
Anti-Inflammatory Agents / therapeutic use
-
Benzhydryl Compounds / therapeutic use
-
Cardiovascular Diseases / etiology*
-
Cardiovascular Diseases / prevention & control
-
Cardiovascular Diseases / therapy
-
Cytokines / physiology
-
Diabetes Complications / drug therapy
-
Diabetes Complications / epidemiology
-
Diabetes Complications / physiopathology*
-
Diabetic Angiopathies / complications
-
Diabetic Angiopathies / physiopathology
-
Diabetic Nephropathies / complications
-
Diabetic Nephropathies / physiopathology
-
Glucosides / therapeutic use
-
Heart / physiopathology
-
Humans
-
Hypertension, Renal / etiology
-
Hypoglycemic Agents / therapeutic use
-
Kidney / physiopathology
-
Oxidative Stress
-
Renin-Angiotensin System / physiology
-
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use
-
Sympathetic Nervous System / physiopathology
Substances
-
Anti-Inflammatory Agents
-
Benzhydryl Compounds
-
Cytokines
-
Glucosides
-
Hypoglycemic Agents
-
Sodium-Glucose Transporter 2 Inhibitors
-
empagliflozin